A Yaz side effect lawsuit was filed in the Superior Court of the State of California, San Francisco, on March 19, 2013.
The plaintiffs include five women who claim to have suffered from DVT (Deep Vein Thrombosis), and other injuries arising from the use of Yaz.
According to court documents, the women contest that Bayer HealthCare Pharmaceuticals – the manufacturer of Yaz, should have known its Yaz birth control product could cause DVT, and that it was a high-risk drug.
Warning from the FDA (Food and Drug Administration):
WARNINGS AND PRECAUTIONS
Thromboembolic Disorders and Other Vascular Problems
Based on presently available information on Yasmin, DRSP-containing COCs may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing the progestin levonorgestrel or some other progestins…
Women taking or who have taken birth control pills that contain Drospirenone have a sevenfold risk of developing blood clots compared to women who take birth control pills that contain levonorgestrel (a synthetic progestogen).
On April 11 2012, the FDA ordered Bayer to provide stronger and more clear warnings on their packaging labels of Yaz and Yasmin blood-clot dangers.
Today, there are more than 13,000 pending Yaz lawsuits, yet Yaz, Yasmin and Ocella remain some of Bayer’s highest-selling pharmaceuticals.
Anyone affected by pulmonary embolism, blood clots, DVT or stroke after taking Yaz, Yasmin, BeYaz, or Ocella should contact a Multi-district Litigation Lawyer (MDL) who handles Yaz cases.
To contact a MDL attorney that represents women who have been harmed by Yaz, Yasmin, BeYaz or Ocella either fill out the form to your right, or visit our site at The Maher Law Firm